Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003472860 | SCV004201761 | likely pathogenic | Achondrogenesis, type IB | 2023-07-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003779114 | SCV004575368 | pathogenic | Achondrogenesis, type IB; Atelosteogenesis type II; Multiple epiphyseal dysplasia type 4; Diastrophic dysplasia | 2023-07-24 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs772015926, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Trp98*) in the SLC26A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC26A2 are known to be pathogenic (PMID: 7923357, 10482955, 11241838). This variant has not been reported in the literature in individuals affected with SLC26A2-related conditions. For these reasons, this variant has been classified as Pathogenic. |